Pretax income is the income that a company earns before paying income taxes. Theragen Etex Co's pretax income for the
three
months ended in Dec. 2024 was ₩-52,880 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-43,159 Mil.
Theragen Etex Co's pretax margin was -80.72%.
During the past 13 years, Theragen Etex Co's highest Pretax Margin was 40.56%. The lowest was -17.29%. And the median was -1.78%.
Theragen Etex Co Pre-Tax Income Historical Data
The historical data trend for Theragen Etex Co's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Theragen Etex Co's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Theragen Etex Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Theragen Etex Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Theragen Etex Co's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Theragen Etex Co's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-43,159 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theragen Etex Co (XKRX:066700) Pre-Tax Income Explanation
Theragen Etex Co's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 13 years, Theragen Etex Co's highest Pretax Margin was 40.56%. The lowest was -17.29%. And the median was -1.78%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theragen Etex Co Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Theragen Etex Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:066700 has been successfully added to your 